Guillo L, Abreu M, Panaccione R, Sandborn WJ, et al. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol 2022 Jan 17. pii: S2468-1253(21)00297.
PMID: 35051383